Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.

Also called NCT01381172

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 160 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01381172
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Czechia, Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01381172. Randomized; no masking; primary purpose treatment. Start 2011-01 (registry gives no type); primary completion 2019-03-19 (actual). Results posted on 2021-09-17.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
Acronym
FIX-HF-5C
Condition
NYHA Class III Heart Failure
Condition
NYHA Class IV Heart Failure
Intervention (Device)
Optimizer System
Intervention (Other)
No intervention: Optimal medical therapy
Lead sponsor
Impulse Dynamics (class: industry)

Record details

Record id
cardio:ct-nct01381172
Content hash
3dc3143bb12f61fb85da7f798cf5f846de3c239f3ca0316773a1e3f399fa5048